On December 22, 2017, Thermo Fisher Scientific (TMO) posted a closing price of $190.4 per share. TMO stock reported its 52-week high of $201.20 on October 26, 2017, when the company released its 3Q17 earnings results.
Thermo Fisher Scientific exceeded its Wall Street earnings and revenue estimates. TMO stock gained ~3.0% on the day, triggered by strong investor sentiment.
TMO witnessed its 52-week low trading activity on December 23, 2016. The stock has recovered well from its lows in the previous year. TMO stock currently trades near its 50-day moving average of $190.50 per share and above its 200-day moving average of $184.70.
On December 4, 2017, investment research firm Leerink Swann decreased Thermo Fisher Scientific’s 2018 and 2019 estimates. The stock registered a decline of more than 5.0% on the day.
TMO stock has returned approximately 34.3% over the last 12 months. Year-to-date (or YTD), TMO stock reported a rise of around 35.0%. Over the past six months, the stock returned ~9.2%. The company has displayed weak momentum in its stock activity over the last few months. Over the past three months, TMO stock has risen ~1.1%.
On December 22, 2017, Thermo Fisher Scientific’s peers Abbott Laboratories (ABT), Boston Scientific (BSX), and Illumina (ILMN) registered returns of approximately 48.0%, 15.0%, and 68.0%, respectively, over the last one-year period.
Thermo Fisher Scientific exceeded the performance of the iShares US Medical Devices ETF (IHI) over the last one-year period. IHI returned ~30.4% over that timeframe.